Open access

Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis
Tuyen Thuy Bich Ho, Alessandro Nasti, Akihiro Seki, Takuya Komura, Hiiro Inui, Takashi Kozaka, Yoji Kitamura, Kazuhiro Shiba, Taro Yamashita, Tatsuya Yamashita, Eishiro Mizukoshi, Kazunori Kawaguchi, Takashi Wada, Masao Honda, Shuichi Kaneko, Yoshio Sakai

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001367; DOI: 10.1136/jitc-2020-001367
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Iuliia Efimova, Elena Catanzaro, Louis Van der Meeren, Victoria D Turubanova, Hamida Hammad, Tatiana A Mishchenko, Maria V Vedunova, Carmela Fimognari, Claus Bachert, Frauke Coppieters, Steve Lefever, Andre G Skirtach, Olga Krysko, Dmitri V Krysko

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001369; DOI: 10.1136/jitc-2020-001369
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy
Sylvain Simon, Valentin Voillet, Virginie Vignard, Zhong Wu, Camille Dabrowski, Nicolas Jouand, Tiffany Beauvais, Amir Khammari, Cécile Braudeau, Régis Josien, Olivier Adotevi, Caroline Laheurte, François Aubin, Charles Nardin, Samuel Rulli, Raphael Gottardo, Nirasha Ramchurren, Martin Cheever, Steven P Fling, Candice D Church, Paul Nghiem, Brigitte Dreno, Stanley R Riddell, Nathalie Labarriere

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001631; DOI: 10.1136/jitc-2020-001631
Correction: Chronic immune checkpoint inhibitor pneumonitis
Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e000840corr1; DOI: 10.1136/jitc-2020-000840corr1
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
Juliane Schuhmacher, Sonja Heidu, Torben Balchen, Jennifer Rebecca Richardson, Camilla Schmeltz, Jesper Sonne, Jonas Schweiker, Hans-Georg Rammensee, Per Thor Straten, Martin Andreas Røder, Klaus Brasso, Cécile Gouttefangeas

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001157; DOI: 10.1136/jitc-2020-001157
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
Erika J Crosby, Amy C Hobeika, Donna Niedzwiecki, Christel Rushing, David Hsu, Peter Berglund, Jonathan Smith, Takuya Osada, William R Gwin III, Zachary C Hartman, Michael A Morse, Herbert Kim Lyerly

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001662; DOI: 10.1136/jitc-2020-001662
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma
Abhishek Tripathi, Edwin Lin, Wanling Xie, Abdallah Flaifel, John A Steinharter, Emily N Stern Gatof, Gabrielle Bouchard, Justin H Fleischer, Nieves Martinez-Chanza, Connor Gray, Charlene Mantia, Linda Thompson, Xiao X Wei, Marios Giannakis, Bradley A McGregor, Toni K Choueiri, Neeraj Agarwal, David F McDermott, Sabina Signoretti, Lauren C Harshman

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001467; DOI: 10.1136/jitc-2020-001467
Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies
Adekunle Odunsi, A J Robert McGray, Anthony Miliotto, Yali Zhang, Jianming Wang, Adebukola Abiola, Cheryl Eppolito, Ruea-Yea Huang

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001237; DOI: 10.1136/jitc-2020-001237
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
Hiroyuki Arai, Yi Xiao, Fotios Loupakis, Natsuko Kawanishi, Jingyuan Wang, Francesca Battaglin, Shivani Soni, Wu Zhang, Christoph Mancao, Bodour Salhia, Shannon M Mumenthaler, Daniel J Weisenberger, Gangning Liang, Chiara Cremolini, Alfredo Falcone, Joshua Millstein, Heinz-Josef Lenz

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001714; DOI: 10.1136/jitc-2020-001714
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
Xiaofeng Chen, Xiaofeng Wu, Hao Wu, Yanhong Gu, Yang Shao, Qianwen Shao, Feipeng Zhu, Xiao Li, Xiaofeng Qian, Jun Hu, Fengjiao Zhao, Weidong Mao, Jing Sun, Jian Wang, Gaohua Han, Changxian Li, Yongxiang Xia, Poshita Kumari Seesaha, Dongqin Zhu, Huajun Li, Junling Zhang, Guoqiang Wang, Xuehao Wang, Xiangcheng Li, Yongqian Shu

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001240; DOI: 10.1136/jitc-2020-001240

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages